Overview

Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin

Status:
Completed

Trial end date:
2019-09-17

Target enrollment:

Participant gender:

Summary

This study is a multicenter, randomized, open-label, parallel, phase IV trial. The purpose of this study efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statin.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Bundang Hospital

Collaborator:

Yuhan Corporation

Treatments:

Ezetimibe
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rosuvastatin Calcium